These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 15595438)

  • 1. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS; Player MR
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput techniques for compound characterization and purification.
    Kyranos JN; Cai H; Zhang B; Goetzinger WK
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):719-28. PubMed ID: 11899611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput characterization and quality control of small-molecule combinatorial libraries.
    Kenseth JR; Coldiron SJ
    Curr Opin Chem Biol; 2004 Aug; 8(4):418-23. PubMed ID: 15288253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality control in combinatorial chemistry: determination of the quantity, purity, and quantitative purity of compounds in combinatorial libraries.
    Yan B; Fang L; Irving M; Zhang S; Boldi AM; Woolard F; Johnson CR; Kshirsagar T; Figliozzi GM; Krueger CA; Collins N
    J Comb Chem; 2003; 5(5):547-59. PubMed ID: 12959555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated medicinal chemistry.
    Koppitz M; Eis K
    Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of high throughput technology for the screening of natural products.
    Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
    Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic systems for high-throughput and combinatorial chemistry.
    Cullen CJ; Wootton RC; de Mello AJ
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):798-806. PubMed ID: 15595440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry and combinatorial chemistry: a short outline.
    Triolo A; Altamura M; Cardinali F; Sisto A; Maggi CA
    J Mass Spectrom; 2001 Dec; 36(12):1249-59. PubMed ID: 11754116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput synthesis of azide libraries suitable for direct "click" chemistry and in situ screening.
    Srinivasan R; Tan LP; Wu H; Yang PY; Kalesh KA; Yao SQ
    Org Biomol Chem; 2009 May; 7(9):1821-8. PubMed ID: 19590777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
    Fischer HP; Heyse S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
    Lundqvist T
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):513-9. PubMed ID: 16022188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based generation of viable leads from small combinatorial libraries.
    Laird ER; Blake JF
    Curr Opin Drug Discov Devel; 2004 May; 7(3):354-9. PubMed ID: 15216940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of structural diversity in combinatorial synthesis.
    Fergus S; Bender A; Spring DR
    Curr Opin Chem Biol; 2005 Jun; 9(3):304-9. PubMed ID: 15939333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinase-focused compound collection: compilation and screening strategy.
    Sun D; Chuaqui C; Deng Z; Bowes S; Chin D; Singh J; Cullen P; Hankins G; Lee WC; Donnelly J; Friedman J; Josiah S
    Chem Biol Drug Des; 2006 Jun; 67(6):385-94. PubMed ID: 16882313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hit discovery and hit-to-lead approaches.
    Keseru GM; Makara GM
    Drug Discov Today; 2006 Aug; 11(15-16):741-8. PubMed ID: 16846802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.